Skip to main content
Top
Published in: Drugs & Aging 6/2017

01-06-2017 | Original Research Article

Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study

Authors: Paola H. Ponte Márquez, Olga H. Torres, Anonio San-José, Xavier Vidal, Antonia Agustí, Francesc Formiga, Alfonso López-Soto, Nieves Ramírez-Duque, Antonio Fernández-Moyano, Juana Garcia-Moreno, Juan A. Arroyo, Domingo Ruiz, on behalf of the Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ Project

Published in: Drugs & Aging | Issue 6/2017

Login to get access

Abstract

Introduction

Previous studies of antihypertensive treatment of older patients have focused on blood pressure control, cardiovascular risk or adherence, whereas data on inappropriate antihypertensive prescriptions to older patients are scarce.

Objectives

The aim of the study was to assess inappropriate antihypertensive prescriptions to older patients.

Methods

An observational, prospective multicentric study was conducted to assess potentially inappropriate prescription of antihypertensive drugs, in patients aged 75 years and older with arterial hypertension (HTN), in the month prior to hospital admission, using four instruments: Beers, Screening Tool of Older Person’s Prescriptions (STOPP), Screening Tool to Alert Doctors to the Right Treatment (START) and Assessing Care of Vulnerable Elders 3 (ACOVE-3). Primary care and hospital electronic records were reviewed for HTN diagnoses, antihypertensive treatment and blood pressure readings.

Results

Of 672 patients, 532 (median age 85 years, 56% female) had HTN. 21.6% received antihypertensive monotherapy, 4.7% received no hypertensive treatment, and the remainder received a combination of antihypertensive therapies. The most frequently prescribed antihypertensive drugs were diuretics (53.5%), angiotensin-converting enzyme inhibitors (ACEIs) (41%), calcium antagonists (32.2%), angiotensin receptor blockers (29.7%) and beta-blockers (29.7%). Potentially inappropriate prescription was observed in 51.3% of patients (27.8% overprescription and 35% underprescription). The most frequent inappropriately prescribed drugs were calcium antagonists (overprescribed), ACEIs and beta-blockers (underprescribed). ACEI and beta-blocker underprescriptions were independently associated with heart failure admissions [beta-blockers odds ratio (OR) 0.53, 95% confidence interval (CI) 0.39–0.71, p < 0.001; ACEIs OR 0.50, 95% CI 0.36–0.70, p < 0.001].

Conclusion

Potentially inappropriate prescription was detected in more than half of patients receiving antihypertensive treatment. Underprescription was more frequent than overprescription. ACEIs and beta-blockers were frequently underprescribed and were associated with heart failure admissions.
Appendix
Available only for authorised users
Literature
6.
go back to reference Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by re. Eur Heart J. 2012 [cited 2014 Jul 10];33:1635–701. http://eurheartj.oxfordjournals.org/content/33/13/1635. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by re. Eur Heart J. 2012 [cited 2014 Jul 10];33:1635–701. http://​eurheartj.​oxfordjournals.​org/​content/​33/​13/​1635.
12.
go back to reference Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008 [cited 2016 Jan 10];46:72–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18218287. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008 [cited 2016 Jan 10];46:72–83. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​18218287.
15.
go back to reference San-José A, Agustí A, Vidal X, Formiga F, López-Soto A, Fernández-Moyano A, et al. Inappropriate prescribing to older patients admitted to hospital: a comparison of different tools of misprescribing and underprescribing. Eur J Intern Med. 2014 [cited 2016 Jan 10];25:710–6. http://www.ncbi.nlm.nih.gov/pubmed/25179678. San-José A, Agustí A, Vidal X, Formiga F, López-Soto A, Fernández-Moyano A, et al. Inappropriate prescribing to older patients admitted to hospital: a comparison of different tools of misprescribing and underprescribing. Eur J Intern Med. 2014 [cited 2016 Jan 10];25:710–6. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​25179678.
17.
18.
go back to reference Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris IS. Effectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016;41:158–69.CrossRefPubMed Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris IS. Effectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016;41:158–69.CrossRefPubMed
20.
go back to reference Schubert I, Küpper-Nybelen J, Ihle P, Thürmann P. Prescribing potentially inappropriate medication (PIM) in Germany’s elderly as indicated by the PRISCUS list. An analysis based on regional claims data. Pharmacoepidemiol Drug Saf. 2013 [cited 2015 Dec 30];22:719–27. http://www.ncbi.nlm.nih.gov/pubmed/23585247. Schubert I, Küpper-Nybelen J, Ihle P, Thürmann P. Prescribing potentially inappropriate medication (PIM) in Germany’s elderly as indicated by the PRISCUS list. An analysis based on regional claims data. Pharmacoepidemiol Drug Saf. 2013 [cited 2015 Dec 30];22:719–27. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​23585247.
23.
go back to reference San-José A, Agustí A, Vidal X, Barbé J, Torres OH, Ramírez-Duque N, et al. An inter-rater reliability study of the prescribing indicated medications quality indicators of the Assessing Care Of Vulnerable Elders (ACOVE) 3 criteria as a potentially inappropriate prescribing tool. Arch Gerontol Geriatr. [cited 2016 Jan 10];58:460–4. http://www.ncbi.nlm.nih.gov/pubmed/24438879. San-José A, Agustí A, Vidal X, Barbé J, Torres OH, Ramírez-Duque N, et al. An inter-rater reliability study of the prescribing indicated medications quality indicators of the Assessing Care Of Vulnerable Elders (ACOVE) 3 criteria as a potentially inappropriate prescribing tool. Arch Gerontol Geriatr. [cited 2016 Jan 10];58:460–4. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​24438879.
24.
go back to reference Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–9. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–9.
27.
go back to reference Coca A, Aranda P, Bertomeu V, Bonet A, Esmatjes E, Guillén F, et al. Estrategias para un control eficaz de la hipertensión arterial en España. Documento de consenso. Rev Clínica Española. 2006;206:510–4.CrossRef Coca A, Aranda P, Bertomeu V, Bonet A, Esmatjes E, Guillén F, et al. Estrategias para un control eficaz de la hipertensión arterial en España. Documento de consenso. Rev Clínica Española. 2006;206:510–4.CrossRef
29.
go back to reference Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. Boston: PWS-Kent Pub. Co; 1988. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. Boston: PWS-Kent Pub. Co; 1988.
31.
go back to reference Banegas JR, Navarro-Vidal B, Ruilope LM, de la Cruz JJ, Lopez-Garcia E, Rodriguez-Artalejo F, et al. Trends in hypertension control among the older population of spain from 2000 to 2001 to 2008 to 2010: role of frequency and intensity of drug treatment. Circ Cardiovasc Qual Outcomes. 2015 [cited 2016 Jan 10];8:67–76. http://circoutcomes.ahajournals.org/content/8/1/67.long. Banegas JR, Navarro-Vidal B, Ruilope LM, de la Cruz JJ, Lopez-Garcia E, Rodriguez-Artalejo F, et al. Trends in hypertension control among the older population of spain from 2000 to 2001 to 2008 to 2010: role of frequency and intensity of drug treatment. Circ Cardiovasc Qual Outcomes. 2015 [cited 2016 Jan 10];8:67–76. http://​circoutcomes.​ahajournals.​org/​content/​8/​1/​67.​long.
34.
go back to reference Coupet M, Renvoize D, Rousseau C, Fresil M, Lozachmeur P, Somme D. [Validity of cardiovascular prescriptions to the guidelines in the elderly according to the STOPP and START method]. Gériatrie Psychol. Neuropsychiatr du Vieil. 2013 [cited 2016 Jan 10];11:237–43. http://www.ncbi.nlm.nih.gov/pubmed/24026128. Coupet M, Renvoize D, Rousseau C, Fresil M, Lozachmeur P, Somme D. [Validity of cardiovascular prescriptions to the guidelines in the elderly according to the STOPP and START method]. Gériatrie Psychol. Neuropsychiatr du Vieil. 2013 [cited 2016 Jan 10];11:237–43. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​24026128.
35.
go back to reference Campanelli CM, Fick DM, Semla T, Beizer J. Potentially inappropriate medication use in older adults: the American Geriatrics Society 2012 Beers Criteria. J Am Geriatr Soc. 2012;60:616–31.CrossRefPubMedCentral Campanelli CM, Fick DM, Semla T, Beizer J. Potentially inappropriate medication use in older adults: the American Geriatrics Society 2012 Beers Criteria. J Am Geriatr Soc. 2012;60:616–31.CrossRefPubMedCentral
40.
go back to reference Gallagher P, Lang PO, Cherubini A, Topinková E, Cruz-Jentoft A, Montero Errasquín B, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol. 2011 [cited 2016 Jan 10];67:1175–88. http://www.ncbi.nlm.nih.gov/pubmed/21584788. Gallagher P, Lang PO, Cherubini A, Topinková E, Cruz-Jentoft A, Montero Errasquín B, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol. 2011 [cited 2016 Jan 10];67:1175–88. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​21584788.
Metadata
Title
Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study
Authors
Paola H. Ponte Márquez
Olga H. Torres
Anonio San-José
Xavier Vidal
Antonia Agustí
Francesc Formiga
Alfonso López-Soto
Nieves Ramírez-Duque
Antonio Fernández-Moyano
Juana Garcia-Moreno
Juan A. Arroyo
Domingo Ruiz
on behalf of the Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ Project
Publication date
01-06-2017
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 6/2017
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-017-0452-z

Other articles of this Issue 6/2017

Drugs & Aging 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine